SEC Form 4 research

Regulus Therapeutics Inc. insider transactions

Recent insider disclosures

No matching recent records; this is not a statement about historical activity.

Officers and directors in the directory

• BALTIMORE DAVID — 14 qualifying
• Collier Kathryn J — 2 qualifying
• Drygin Denis — 2 qualifying
• FOLETTA MARK G — 140 qualifying
• PARSHALL B LYNNE — 242 qualifying
• Hagan Joseph P — 34 qualifying
• PAPADOPOULOS STELIOS — 85 qualifying
• Klassen Preston — 11 qualifying
• CARTER BRUCE L A — 48 qualifying
• RASTETTER WILLIAM H — 48 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.